Alkermes plc

NASDAQ:ALKS   9:49:06 AM EDT
26.77
+0.14 (+0.53%)
Products

FDA Accepts Alkermes' Resubmission Of New Drug Application For ALKS 3831

Published: 12/29/2020 12:19 GMT
Alkermes plc (ALKS) - FDA Accepts Alkermes' Resubmission of New Drug Application for Alks 3831.
Alkermes Plc - FDA Sets PDUFA Target Action Date of June 1, 2021.